Neoplasms of the immune system in rheumatoid arthritis

The American Journal of Medicine

Volumn 78, Issue 1 SUPPL. A, 1985, Pages 22-28

  Symmons, Deborah P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; PENICILLAMINE; PHENYLBUTAZONE;

CANCER; CLINICAL ARTICLE; DIAGNOSIS; EPIDEMIOLOGY; ETIOLOGY; HUMAN; IMMUNITY; JOINT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HODGKIN DISEASE; HUMAN; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA; LYMPHOMA, LARGE-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGE; PENICILLAMINE; PHENYLBUTAZONE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; SUPPORT, NON-U.S. GOV'T;

EID: 0021925246     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(85)90241-4     Document Type: Article

References (38)

1. An unusual protein component of high molecular weight in the screen of certain patients with rheumatoid arthritis
2. Serum levels of IgG, IgM, and IgA in rheumatoid arthritis
3. Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis
4. Characterization of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis
5. Cancer morbidity in rheumatoid arthritis
6. Cause of death in rheumatoid arthritis
7. Lymphoproliferative malignancy in rheumatoid arthritis; a study of 20 cases
8. Report of nomenclature committee
9. Malignant lymphomas other than Hodgkin's disease
10. Increased risk of lymphoma in sicca syndrome
11. Systemic lupus erythematosus and lymphoma
12. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
13. Malignant lymphomas of the thyroid
14. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm
15. Suppressor T-cell dysfunction as a possible cause for autoimmunity
16. Rheumatoid factor synthesis by isolated synovial cells
17. Histochemical discrimination of HLA-DR positive populations in the normal and arthritic synovial lining
18. Response of the rheumatoid synovial membrane to exogenous immunization
19. Multiple abnomalities in immunoregulatory function of synovial compartment T cells in patients with rheumatoid arthritis
20. Rheumatoid lymphadenopathy
21. An evaluation of rheumatoid lymphadenopathy by follow-up
22. The lymphoreticular system and amyloidosis in rheumatoid and experimental arthritis
23. Circulating activated lymphocytes in rheumatoid arthritis: a marker of synovial inflammation
24. Gold therapy in rheumatoid arthritis
25. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis: a preliminary report
26. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout
27. Chloroquine diphosphate in rheumatoid arthritis
28. Controlled trial of D-penicillamine in severe rheumatoid arthritis
29. Phenylbutazone and leukaemia
30. Phenylbutazone and leukaemia
31. The effect of D-penicillamine on human T-cell helper function
32. Leukaemia-like appearances in mice given penicillamine
33. Chronic lymphocytic leukaemia after treatment with penicillamine
34. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs
35. Causes of death in patients with rheumatoid arthritis during a period of 5 years